Literature DB >> 7122164

Paroxysmal atrial tachycardia in infancy: long-term follow-up study of 49 subjects.

A Lundberg.   

Abstract

A follow-up study of 49 individuals with paroxysmal atrial tachycardia in infancy is reported. Forty subjects had supraventricular tachycardia and nine had atrial flutter/fibrillation. The mean follow-up period was 24 years. Males whose ECGs showed preexcitation displayed the highest rate of recurrences (approximately 60%) in the long-term follow-up. Approximately 30% of the subjects without preexcitation in the ECG displayed episodes of supraventricular tachycardia in their third decade. Eight-six percent of the children of the subjects in the present series were males. The prognosis is good in the absence of congenital heart disease.

Entities:  

Mesh:

Year:  1982        PMID: 7122164

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  4 in total

1.  Paroxysmal supraventricular tachycardia in the rural setting- case reports and review.

Authors:  Thiraviam P Ashok; Sanjay Sharma; Mahesh Jain
Journal:  Oman Med J       Date:  2008-04

2.  Supraventricular tachycardia in children: a report of three cases, diagnosis and current management.

Authors:  P Venugopalan; A Shakeel; A Al Amry; S Jaya
Journal:  J Sci Res Med Sci       Date:  2000-01

3.  Prospective assessment after pediatric cardiac ablation: design and implementation of the multicenter study.

Authors:  George F Van Hare; Dorit Carmelli; W Mcfate Smith; John Kugler; Michael Silka; Richard Friedman; Dianne Atkins; Philip Saul; Michael Schaffer; Craig Byrum; Ann Dunnigan; Steven Colan; Gerald Serwer
Journal:  Pacing Clin Electrophysiol       Date:  2002-03       Impact factor: 1.976

4.  Surgical management of children and young adults with the Wolff-Parkinson-White syndrome.

Authors:  M Dick; A Vaporicyan; E L Bove; F Morady; W A Scott; B I Bromberg; G A Serwer; S F Bolling; D M Behrendt; A Rosenthal
Journal:  Heart Vessels       Date:  1988       Impact factor: 2.037

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.